Tag Archives: EV therapeutics

Engineered extracellular vesicles could extend therapeutic delivery beyond individual cells by coordinating changes across diseased tissue microenvironments through targeted cargo and...

Extracellular vesicles could provide cardiovascular biomarkers through liquid biopsy while offering new approaches for therapeutic delivery and...

ANZSEV 2026 will showcase advances in extracellular vesicles research, highlighting emerging technologies, diagnostics, therapeutics, and opportunities for collaboration across the EV community...

Researchers are investigating extracellular vesicles derived from mesenchymal stem cells as a potential therapy to reduce neuroinflammation, promote nerve repair, and alleviate chronic neuropathic pain...

Growing interest in extracellular vesicles and exosomes highlights their potential as drug delivery vehicles, biomarkers, and regulators of cell communication across medicine, biotechnology...

Extracellular vesicles and exosomes are emerging as powerful biomarkers and delivery vehicles, with advances in nanotechnology improving EV...

Researchers show that protrusion-derived extracellular vesicles can deliver functional proteins like Rac1 and Cas12f with exceptional efficiency, offering a promising new platform for therapeutic protein...

The NextGen EV Therapeutics Forum highlighted global advances in extracellular vesicles for precision medicine, including targeted exosome platforms for...

Cells secrete extracellular vesicles (EVs) to external environments to achieve cellular homeostasis and cell-to-cell communication. Their therapeutic potential has been constantly spotlighted since they mirror both cytoplasmic and membranous...

Extracellular vesicles (EVs) represent a class of cell secreted organelles which naturally contain biomolecular cargo such as miRNA, mRNA and proteins. EVs mediate intercellular communication, enabling the transfer of functional nucleic acids from the cell of origin to the recipient ...